Rituximab-Based Treatment, HCV Replication, and Hepatic Flares

Rituximab, a chimeric mouse-human monoclonal antibody directed to the CD20 antigen expressed on pre-B lymphocytes and mature lymphocytes, causes a profound B-cell depletion. Due to its peculiar characteristics, this drug has been used to treat oncohaematological diseases, B cell-related autoimmune d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagnelli, Evangelista, Pisaturo, Mariantonietta, Sagnelli, Caterina, Coppola, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420110/
https://www.ncbi.nlm.nih.gov/pubmed/22919406
http://dx.doi.org/10.1155/2012/945950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420110/
https://www.ncbi.nlm.nih.gov/pubmed/22919406
http://dx.doi.org/10.1155/2012/945950

Ejemplares similares